Colchicine Patent Expiration
Colchicine is Used for treating and reducing the risk of cardiovascular events, acute myocardial infarction, atherosclerotic vascular disease, and inflammation. It was first introduced by Takeda Pharmaceuticals Usa Inc
Colchicine Patents
Given below is the list of patents protecting Colchicine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Colcrys | US7601758 | Methods for concomitant administration of colchicine and macrolide antibiotics in the treatment of gout flares | Feb 10, 2029 | Takeda Pharms Usa |
| Colcrys | US7619004 | Methods for concomitant administration of colchicine and macrolide antibiotics | Dec 03, 2028 | Takeda Pharms Usa |
| Colcrys | US7820681 | Methods for concomitant administration of colchicine and a second active agent | Feb 17, 2029 | Takeda Pharms Usa |
| Colcrys | US7906519 | Methods for concomitant administration of colchicine and a second active agent | Feb 17, 2029 | Takeda Pharms Usa |
| Colcrys | US7915269 | Methods for concomitant administration of colchicine and a second active agent | Feb 17, 2029 | Takeda Pharms Usa |
| Colcrys | US7935731 | Methods for concomitant administration of colchicine and macrolide antibiotics | Dec 03, 2028 | Takeda Pharms Usa |
| Colcrys | US7964647 | Colchicine compositions and methods | Oct 06, 2028 | Takeda Pharms Usa |
| Colcrys | US7964648 | Methods for concomitant administration of colchicine and a second active agent | Oct 06, 2028 | Takeda Pharms Usa |
| Colcrys | US7981938 | Colchicine compositions and methods | Oct 06, 2028 | Takeda Pharms Usa |
| Colcrys | US8093296 | Methods for concomitant administration of colchicine and macrolide antibiotics | Oct 06, 2028 | Takeda Pharms Usa |
| Colcrys | US8093297 | Methods for concomitant administration of colchicine and a second active agent | Oct 06, 2028 | Takeda Pharms Usa |
| Colcrys | US8093298 | Methods for concomitant administration of colchicine and macrolide antibiotics | Oct 06, 2028 | Takeda Pharms Usa |
| Colcrys | US8097655 | Methods for concomitant administration of colchicine and macrolide antibiotics | Oct 06, 2028 | Takeda Pharms Usa |
| Colcrys | US8415395 | Colchicine compositions and methods | Oct 06, 2028 | Takeda Pharms Usa |
| Colcrys | US8415396 | Colchine compositions and methods | Oct 06, 2028 | Takeda Pharms Usa |
| Colcrys | US8440721 | Methods for concomitant administration of colchicine and a second active agent | Feb 17, 2029 | Takeda Pharms Usa |
| Colcrys | US8440722 | Methods for concomitant administration of colchicine and a second active agent | Feb 17, 2029 | Takeda Pharms Usa |
| Gloperba | US10226423 | Colchicine drug-to-drug interactions | Dec 20, 2037 | Scilex Pharms |
| Gloperba | US10383820 | Colchicine drug-to-drug interactions | Nov 22, 2036 | Scilex Pharms |
| Gloperba | US10383821 | Colchicine drug-to-drug interactions | Nov 22, 2036 | Scilex Pharms |
| Gloperba | US9907751 | Composition and method of use of colchicine oral liquid | Nov 22, 2036 | Scilex Pharms |
| Lodoco | US10130585 | Methods of treating and/or preventing cardiovascular disease | May 09, 2034 | Agepha Pharma Fz |
| Lodoco | US10206891 | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent | Nov 01, 2033 | Agepha Pharma Fz |
| Lodoco | US10265281 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | Nov 01, 2033 | Agepha Pharma Fz |
| Lodoco | US10842762 | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent | Nov 01, 2033 | Agepha Pharma Fz |
| Lodoco | US11026899 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | Nov 01, 2033 | Agepha Pharma Fz |
| Lodoco | US11026900 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | Nov 01, 2033 | Agepha Pharma Fz |
| Lodoco | US11026901 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | Nov 01, 2033 | Agepha Pharma Fz |
| Lodoco | US11944594 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | Nov 01, 2033 | Agepha Pharma Fz |
| Lodoco | US11944595 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | Nov 01, 2033 | Agepha Pharma Fz |
| Lodoco | US9744144 | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent | Nov 01, 2033 | Agepha Pharma Fz |
| Mitigare | US8927607 | Methods of colchicine administration | Aug 22, 2033 | Hikma Intl Pharms |
| Mitigare | US9399036 | Methods of colchicine administration | Aug 22, 2033 | Hikma Intl Pharms |
| Mitigare | US9555029 | Methods of colchicine administration | Aug 22, 2033 | Hikma Intl Pharms |
| Mitigare | US9675613 | Methods of colchicine administration | Aug 22, 2033 | Hikma Intl Pharms |
| Mitigare | US9789108 | Methods of colchicine administration | Aug 22, 2033 | Hikma Intl Pharms |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Colchicine Generics
Several generic applications have been filed for Colchicine. The first generic version for Colchicine was by Amneal Pharmaceuticals and was approved on Sep 28, 2016. And the latest generic version is by Granules Pharmaceuticals Inc and was approved on Apr 29, 2024.
Given below is the list of companies who have filed for Colchicine generic.
1. MYLAN
Mylan Pharmaceuticals Inc has filed for 1 generic for Colchicine. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | tablet | Discontinued | ORAL | N/A | Sep 16, 2019 |
2. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Colchicine. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | tablet | Prescription | ORAL | AB | Sep 6, 2019 |
3. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 1 generic for Colchicine. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | capsule | Prescription | ORAL | AB | Apr 29, 2024 |
4. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 1 generic for Colchicine. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | tablet | Prescription | ORAL | AB | Mar 10, 2022 |
5. ANNORA PHARMA
Annora Pharma Private Ltd has filed for 1 generic for Colchicine. Given below are the details of the strengths of this generic introduced by Annora Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | capsule | Prescription | ORAL | AB | Apr 29, 2024 |
6. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 1 generic for Colchicine. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | tablet | Prescription | ORAL | AB | Aug 13, 2021 |
7. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 1 generic for Colchicine. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | tablet | Prescription | ORAL | AB | Sep 28, 2016 |
8. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 1 generic for Colchicine. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | tablet | Prescription | ORAL | AB | Feb 8, 2019 |
9. ENDO OPERATIONS
Endo Operations Ltd has filed for 1 generic for Colchicine. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG
(reference standard) | tablet | Prescription | ORAL | AB | Aug 12, 2021 |
10. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Colchicine. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | tablet | Prescription | ORAL | AB | Feb 19, 2019 |
| 0.3MG | tablet | Prescription | ORAL | N/A | Nov 14, 2019 |
11. GRANULES
Granules Pharmaceuticals Inc has filed for 1 generic for Colchicine. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | capsule | Prescription | ORAL | AB | Apr 29, 2024 |
12. WATSON LABS INC
Watson Laboratories Inc has filed for 1 generic for Colchicine. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | tablet | Prescription | ORAL | AB | Jul 31, 2019 |